Last Price$3.22NASDAQ Previous Close - Last Trade as of 4:00PM ET 9/22/20

Today's Change-0.03(0.92%)
Bid (Size)$3.18 (35)
Ask (Size)$3.22 (50)
Day Low / High$3.12 - 3.31

View Pharmaceuticals: Major IndustryPeer Comparison as of 09/22/2020


OPKO Health Inc ( NASDAQ )

Price: $3.22
Change: -0.03 (0.92%)
Volume: 60.00
4:00PM ET 9/22/2020

Xencor Inc ( NASDAQ )

Price: $38.85
Change: +0.43 (1.12%)
Volume: 303.2 K
4:00PM ET 9/22/2020

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A

Aimmune Therapeutics Inc ( NASDAQ )

Price: $34.31
Change: -0.01 (0.03%)
Volume: 1.1 M
4:00PM ET 9/22/2020

Kodiak Sciences Inc ( NASDAQ )

Price: $52.26
Change: +1.05 (2.05%)
Volume: 259.6 K
4:00PM ET 9/22/2020

Read more news Recent News

Opko Health to Launch Phase 2 Testing of COVID-19 Treatment Candidate; Shares Rise
8:05AM ET 9/15/2020 MT Newswires

Opko Health (OPK) said Tuesday it will launch the second phase of the clinical trial of its COVID-19 treatment candidate Rayaldee (calcifediol), starting...

Opko Health Unit Begins COVID-19 Testing For School Employees in New York
9:10AM ET 9/02/2020 MT Newswires

Opko Health Inc's (OPK) unit BioReference Laboratories Inc. said Wednesday it has started testing principals, teachers and other staff for COVID-19 across...

Opko Health Unit Launches New Technology for DNA Mutational Profiling of Tumors
5:31AM ET 9/02/2020 MT Newswires

Opko Health (OPK) subsidiary BioReference Laboratories and its specialty oncology division GenPath announced late Tuesday the new OnkoSight Advanced...

Opko Health Slips As BioReference Unit Confirms False Positive Covid-19 Tests For NFL
1:03PM ET 8/24/2020 MT Newswires

Opko Health (OPK) was down more than 4% Monday after its BioReference Laboratories unit said it mistakenly issued false positive COVID-19 PCR test results...

View all Commentary and Analysis

OPKO Health (OPK) Stock Sinks As Market Gains: What You Should Know
4:45PM ET 9/22/2020 Zacks

OPKO Health (OPK) closed the most recent trading day at $3.22, moving -0.92% from the previous...

OPKO Health, Inc. (OPK) Presents at H. C. Wainwright 22nd Annual Global Investment Conference (Transcript)
12:39PM ET 9/15/2020 Seeking Alpha

OPKO's Rayaldee Drug Could Be A Leading COVID-19 Treatment
12:44PM ET 8/20/2020 Seeking Alpha

Wall Street Breakfast: Big Beats From Big Tech
7:04AM ET 7/31/2020 Seeking Alpha

Company Profile

Business DescriptionOPKO Health, Inc. engages in the provision of healthcare services. It operates through the following segments: Diagnostics, Pharmaceuticals, and Corporate. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL. View company web site for more details
Address4400 Biscayne Boulevard
Miami, Florida 33137
Number of Employees5,690
Recent SEC Filing09/15/20208-K
Chairman & Chief Executive OfficerPhillip Frost
Chief Financial Officer & Senior Vice PresidentAdam E. Logal
Vice Chairman & Chief Technical OfficerJane H. Hsaio
Director & Executive Vice President-AdministrationSteven D. Rubin

Company Highlights

Price Open$3.30
Previous Close$3.22
52 Week Range$1.12 - 6.47
Market Capitalization$2.2 B
Shares Outstanding669.8 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement11/03/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.24
Beta vs. S&P 500N/A
Revenue$990.3 M
Net Profit Margin-20.69%
Return on Equity-12.50%

Analyst Ratings as of 02/27/2020

Consensus RecommendationConsensus Icon
Powered by Factset